Search alternatives:
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
-
1761
-
1762
High-throughput drug screen reveals HDAC and proteasome inhibitors as potent drug classes against synovial sarcoma.
Published 2017“…<p>(A) Compounds resulting in measured relative cell viability of less than 50% are annotated as hits (blue). …”
-
1763
-
1764
-
1765
Lysine 50 of Tat regulates expression of C5, CRLF2, APBA1, and BDNF genes.
Published 2017“…<p>THP-1Tat-Flag and THP-1Tat K50ATat-Flag cell lines (generated from independent experiments described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0179882#pone.0179882.g005" target="_blank">Fig 5</a>) were differentiated to macrophages with PMA for 24 and 48 hours. …”
-
1766
-
1767
HDAC inhibition prevents aggresome formation in response to proteasome inhibitors, and combination treatment leads to endoplasmic reticulum stress.
Published 2017“…<p>(A) Knockdown of HDAC6 results in decreased levels of LC3B in the SYO-1 synovial sarcoma cell line. …”
-
1768
-
1769
-
1770
-
1771
-
1772
-
1773
-
1774
-
1775
-
1776
-
1777
-
1778
-
1779
-
1780